REVIEW
Add like
Add dislike
Add to saved papers

Hip and sacroiliac disease: selected disorders and their management with physical therapy.

Many problems in the hip area show movement dysfunctions of the hip joint in combination with the lumbar spine, sacroiliac joint, neurodynamic structures, and the muscular systems. Muscle strain injuries pertinent to the canine hip have been reported in the iliopsoas, pectineus, gracilis, sartorius, tensor fasciae latae, rectus femoris, and semitendinosus muscles. Physical diagnoses of this type of injury require palpation skills and the ability to specifically stretch the suspected musculotendinous tissue. Treatments shall incorporate modalities, stretches, specific exercises, and advisement on return to normal activity. Canine hip dysplasia (CHD) is a common finding in many large breed dogs. Physical treatments, preventative therapies, and rehabilitation could have a large role to play in the management of nonsurgical CHD patients with the goal to create the best possible musculoskeletal environment for pain-free hip function and to delay or prevent the onset of degenerative joint disease. Osteoarthritic hip joints can benefit from early detection and subsequent treatment. Physical therapists have long utilized manual testing techniques and clinical reasoning to diagnose early-onset joint osteoarthritis and therapeutic treatments consisting of correcting muscle dysfunctions, relieving pain, joint mobilizations, and advisement on lifestyle modifications could be equally beneficial to the canine patient. As well, sacroiliac joint dysfunctions may also afflict the dog. An understanding of the anatomy and biomechanics of the canine sacroiliac joint and application of clinical assessment and treatment techniques from the human field may be substantially beneficial for dogs suffering from lumbopelvic or hindlimb issues.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app